These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20539300)

  • 1. Meal fat storage in subcutaneous adipose tissue: comparison of pioglitazone and glipizide treatment of type 2 diabetes.
    Basu A; Basu R; Pattan V; Rizza RA; Jensen MD
    Obesity (Silver Spring); 2010 Oct; 18(10):2058-60. PubMed ID: 20539300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes.
    Basu A; Jensen MD; McCann F; Nandy D; Mukhopadhyay D; McConnell JP; Rizza RA
    Endocr Pract; 2007; 13(2):147-52. PubMed ID: 17490928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial.
    Smith SR; De Jonge L; Volaufova J; Li Y; Xie H; Bray GA
    Metabolism; 2005 Jan; 54(1):24-32. PubMed ID: 15562376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes.
    Basu A; Jensen MD; McCann F; Mukhopadhyay D; Joyner MJ; Rizza RA
    Diabetes Care; 2006 Mar; 29(3):510-4. PubMed ID: 16505497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotope tracer measures of meal fatty acid metabolism: reproducibility and effects of the menstrual cycle.
    Uranga AP; Levine J; Jensen M
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E547-55. PubMed ID: 15507534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-specific differences in leg fat uptake are revealed with a high-fat meal.
    Votruba SB; Jensen MD
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1115-23. PubMed ID: 16803856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pioglitazone and glipizide on platelet function in patients with type 2 diabetes.
    Xiao CC; Ren A; Yang J; Ye SD; Xing XN; Li SM; Chen C; Chen RP
    Eur Rev Med Pharmacol Sci; 2015; 19(6):963-70. PubMed ID: 25855920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    Maffioli P; Fogari E; D'Angelo A; Perrone T; Derosa G
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meal fatty acid uptake in human adipose tissue: technical and experimental design issues.
    Romanski SA; Nelson RM; Jensen MD
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E447-54. PubMed ID: 10913046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term regional meal fat storage in nonobese humans is not a predictor of long-term regional fat gain.
    Votruba SB; Jensen MD
    Am J Physiol Endocrinol Metab; 2012 May; 302(9):E1078-83. PubMed ID: 22338076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of direct adipose tissue free fatty acid storage during mixed meal ingestion and high free fatty acid concentration conditions.
    Zhang L; Hames KC; Jensen MD
    Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E208-E218. PubMed ID: 33196297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meal fatty acid uptake in visceral fat in women.
    Votruba SB; Mattison RS; Dumesic DA; Koutsari C; Jensen MD
    Diabetes; 2007 Oct; 56(10):2589-97. PubMed ID: 17664244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fat content is linked to inflammatory changes in subcutaneous adipose tissue in type 2 diabetes patients.
    Jansen HJ; Vervoort GM; van der Graaf M; Stienstra R; Tack CJ
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):661-6. PubMed ID: 23167778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue.
    McLaughlin TM; Liu T; Yee G; Abbasi F; Lamendola C; Reaven GM; Tsao P; Cushman SW; Sherman A
    Obesity (Silver Spring); 2010 May; 18(5):926-31. PubMed ID: 19910937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
    Kodama N; Tahara N; Tahara A; Honda A; Nitta Y; Mizoguchi M; Kaida H; Ishibashi M; Abe T; Ikeda H; Narula J; Fukumoto Y; Yamagishi S; Imaizumi T
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4438-45. PubMed ID: 24030946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus.
    Jonker JT; Lamb HJ; van der Meer RW; Rijzewijk LJ; Menting LJ; Diamant M; Bax JJ; de Roos A; Romijn JA; Smit JW
    J Clin Endocrinol Metab; 2010 Jan; 95(1):456-60. PubMed ID: 19915017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
    Cusi K; Orsak B; Bril F; Lomonaco R; Hecht J; Ortiz-Lopez C; Tio F; Hardies J; Darland C; Musi N; Webb A; Portillo-Sanchez P
    Ann Intern Med; 2016 Sep; 165(5):305-15. PubMed ID: 27322798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional uptake of meal fatty acids in humans.
    Jensen MD; Sarr MG; Dumesic DA; Southorn PA; Levine JA
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1282-8. PubMed ID: 12915396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.